Abstract
Could poly(ADP–ribose) polymerase inhibitors provide a major advance in the therapy of difficult-to-treat tumours, such as triple-negative breast cancer?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Opar, A. Novel anticancer strategy targets DNA repair. Nat Rev Drug Discov 8, 437–438 (2009). https://doi.org/10.1038/nrd2916
Issue Date:
DOI: https://doi.org/10.1038/nrd2916
This article is cited by
-
Emerging companion diagnostics for cancer drugs
Nature Reviews Drug Discovery (2010)
-
Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome
Breast Cancer Research and Treatment (2010)